Park Square Financial Group’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.08K Sell
75
-65
-46% -$3.17K 0.04% 135
2026
Q1
$6K Buy
+140
New +$6.02K 0.05% 139
2025
Q4
Sell
-96
Closed -$3.96K 265
2025
Q3
$3.96K Sell
96
-104
-52% -$4.18K 0.02% 206
2025
Q2
$8.81K Buy
+200
New +$7.99K 0.01% 621

Other funds holding EXEL

Park Square Financial Group's EXEL Position: Q2 2026 in Review

Park Square Financial Group reduced its Exelixis (EXEL) stake by 46% in Q2 2026, selling an estimated $3.17K and leaving 75 shares worth $4.08K. The position accounts for 0.04% of the portfolio, ranked #135.

Park Square Financial Group first reported a position in EXEL in Q2 2025 and has held it in 4 quarters since. The position peaked at $8.81K in Q2 2025. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Park Square Financial Group held 75 shares of Exelixis worth $4.08K as of Q2 2026.
  • Park Square Financial Group sold 65 Exelixis shares in Q2 2026, an estimated $3.17K.
  • Exelixis made up 0.04% of Park Square Financial Group's portfolio in Q2 2026, its #135 holding.
  • Park Square Financial Group first reported a position in Exelixis in Q2 2025 and has held it in 4 quarters since.
  • Park Square Financial Group's Exelixis position peaked at $8.81K in Q2 2025.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Park Square Financial Group's 13F filing for Q2 2026, filed 31 Jul 2026.